Bolt Biotherapeutics, Inc. (BOLT:NASDAQ) closed at $4.06 on October 16, 2026, down 5.13% on the day. The stock trades 43.6% below its 52-week high of $7.20 and 31.0% above its 52-week low of $3.10. Over the past year, it lost 27.7%. Bolt Biotherapeutics, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| 0.00% | +16.80% | -5.25% | -17.67% | -27.68% |
In 252 trading sessions since October 15, 2025, BOLT closed higher on 121 days (48%). Its best day was March 16, 2026 (+16.11%) and its worst was August 12, 2026 (-13.32%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 3 times.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
Find more stocks like BOLT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.